Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-10

Clinical Trial Update: The Effect and Safety of Recombinant Fibroblast Growth Factor-1 for Carpal Tunnel Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect and safety of recombinant fibroblast growth factor-1 in Carpal Tunnel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant fibroblast growth factor-1 (fibroblast growth factor-1)

Snippet

Sponsor: Tri-Service General Hospital | Conditions: Carpal Tunnel Syndrome | NA | Status: COMPLETED